AR115411A2 - 8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv - Google Patents

8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv

Info

Publication number
AR115411A2
AR115411A2 ARP190101358A ARP190101358A AR115411A2 AR 115411 A2 AR115411 A2 AR 115411A2 AR P190101358 A ARP190101358 A AR P190101358A AR P190101358 A ARP190101358 A AR P190101358A AR 115411 A2 AR115411 A2 AR 115411A2
Authority
AR
Argentina
Prior art keywords
methyl
dpp
piperidin
amino
xanthines
Prior art date
Application number
ARP190101358A
Other languages
English (en)
Spanish (es)
Inventor
Leo Thomas
Mohammad Tadayyon
Matthias Eckhardt
Elke Langkopf
Frank Himmelsbach
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR115411A2 publication Critical patent/AR115411A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
ARP190101358A 2004-02-18 2019-05-22 8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv AR115411A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004008112A DE102004008112A1 (de) 2004-02-18 2004-02-18 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
AR115411A2 true AR115411A2 (es) 2021-01-13

Family

ID=34813493

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190101358A AR115411A2 (es) 2004-02-18 2019-05-22 8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv

Country Status (5)

Country Link
CN (1) CN1980930B (ru)
AR (1) AR115411A2 (ru)
DE (1) DE102004008112A1 (ru)
UA (1) UA87835C2 (ru)
ZA (1) ZA200604281B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008002427A1 (es) * 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
DE102008010661A1 (de) * 2008-02-22 2009-09-03 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Verfahren zur Herstellung von Pyridin-2-Boronsäure und Derivaten davon
CN102311448B (zh) * 2010-07-07 2014-02-19 中国科学院广州生物医药与健康研究院 噻吩并嘧啶酮类dpp-iv抑制剂
EA030121B1 (ru) * 2011-07-15 2018-06-29 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные хиназолины, их получение и их применение в фармацевтических композициях
CN103450201B (zh) * 2012-05-30 2017-04-12 博瑞生物医药（苏州）股份有限公司 手性8‑（3‑氨基哌啶‑1‑基）‑黄嘌呤的制备方法
CN103709163B (zh) * 2012-09-29 2016-12-21 齐鲁制药有限公司 黄嘌呤衍生物、其制备方法及用途
CN103319483B (zh) * 2012-10-19 2016-08-03 药源药物化学（上海）有限公司 一种利拉列汀重要中间体的制备方法
CN103936740B (zh) * 2013-01-23 2016-06-29 成都苑东生物制药股份有限公司 黄嘌呤衍生物
CN106188058B (zh) * 2015-05-29 2020-11-06 江苏天士力帝益药业有限公司 黄嘌呤衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100926247B1 (ko) * 2001-02-24 2009-11-12 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 크산틴 유도체를 포함하는 약제학적 조성물 및 이의제조방법

Also Published As

Publication number Publication date
DE102004008112A1 (de) 2005-09-01
UA87835C2 (en) 2009-08-25
CN1980930A (zh) 2007-06-13
CN1980930B (zh) 2012-11-21
ZA200604281B (en) 2007-10-31

Similar Documents

Publication Publication Date Title
AR115411A2 (es) 8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv
EA201100969A1 (ru) Солевые формы органического соединения
TNSN05320A1 (en) Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
UY29149A1 (es) Tiazolil-dihidro-indazoles
ATE526331T1 (de) Pyrrolopyrimidine für pharmazeutische zusammensetzungen
PE20060316A1 (es) Derivados de prolina como inhibidores de dipeptidil peptidasa-iv
ATE427926T1 (de) Cycloalkylaminderivate
PE20110235A1 (es) Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
GT200500272A (es) 2-anilinopirimidinas sustituidas como inhibidores de la quinasa del ciclo celular o del receptor de la tirosina quinasa, su preparacion y su uso como medicamentos
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
UY27946A1 (es) 8-(3-amino-piperidin-1 il)- xantinas, su preparación y su utilización como medicamentos
TW200631580A (en) Substituted benzoquinolizine derivatives
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
PE20061354A1 (es) Compuestos 2-amino-4-oxobutil como inhibidores de la dipeptidil peptidas-iv
PE20091383A1 (es) DERIVADOS DE IMIDAZO-[1,2-a]PIRIDINA COMO INHIBIDORES DE ALK-5 Y ALK-4
GB0412769D0 (en) Organic compounds
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
ECSP077130A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos
UY29885A1 (es) 2-acilaminotiazol-4-carboxamidas insecticidas
CL2009000512A1 (es) Compuestos heterociclicos sustituidos derivados de imidazo[4,5-d]piridazina, imidazo[4,5-c]piridazina, imidazo[4,5d]pirimidina, entre otros; composicion farmaceutica que comprende a dichos comppuestos; y uso para tratar el virus de la hepatitis c.
ATE507854T1 (de) Zellselektive implantatoberfläche mit gesteuerter freisetzung bioaktiver wirkstoffe
DOP2009000073A (es) Inhibidores de cinasa que catalizan la transferencia de fosforilo y/o que enlazan nucleótidos atp/gtp.
CL2004000979A1 (es) Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida.

Legal Events

Date Code Title Description
FB Suspension of granting procedure